alternative indicators (Ct, serology)

Includes indicators of trachoma prevalence aside from the standard grading of trachomatous follicular (TF) and trachomatous trichiasis (TT). This includes, but is not limited to, Chlamydia trachomatous infection, serology, trachomatous inflammation (TI), photographic grading, etc.

alternative treatment strategies

Refers to a deviation from the standard practice of annual MDAs for the control of trachoma. This could be in the context of research, catch-up rounds, enhanced treatment strategies, or other programmatic decisions leading to distribution of antibiotics outside standard WHO guidelines.

coverage

Includes references to MDA coverage, tools for assessing coverage, and analysis of coverage as it relates to trachoma prevalence outcomes

COVID

Includes recommendations and decisions related to the COVID-19 pandemic and the impact of the pandemic on national trachoma programs and the global program at large.

cross-border

Refers to trans-national coordination of trachoma program activities including cross-border MDAs, regional cross-border meetings, and other forms of communication and coordination.

dosing

Refers to the age and height determined guidelines for distribution of azithromycin tablets and powder for oral suspension (POS) for trachoma control

end game

Includes recommendations and conclusions related to dossier preparation and submission for validation, supply chain considerations for the end of MDAs, post-validation surveillance, and other topics related to national and global targets for the elimination of trachoma as public health problem.

evaluation units

Refers to recommendations on the geographic boundaries of sampling frames for trachoma prevalence surveys. This includes recommendations for population size, inclusion of urban areas and refugee camps in surveys, handling changes to boundaries between evaluation and implementation, and other special considerations.

funding

Refers to financial support for trachoma program related activities.

F&E/WASH

Includes facial cleanliness and environmental hygiene as well as other topics related to water, sanitation, and hygiene in the context of trachoma control and elimination.

ICTC

Refers to collaboration with the International Coalition for Trachoma Control (ICTC) and related advocacy efforts.

insecurity

Refers to violence, political unrest, and other instability and their impact on trachoma program implementation.

persistence

Refers to trachoma-endemic districts that have not achieved or sustained elimination targets after standard SAFE implementation. Barring a standardized definition, this field includes districts with high baseline TF that are not seeing reduction below threshold, those that are close to the TF threshold but have not achieved it, and those that achieved the TF threshold at TIS but are found over threshold at TSS.

recommendations for ITI management

Refers to suggestions for ITI leadership to provide support to national programs (including supply chain) as well as recommendations for advocacy, support for research, and country visits. This also includes recommendations for communications to national programs.

research

Includes research on all aspects of SAFE implementation.

special populations

Special populations refers to all populations that require programs to be tailored to ensure the equitable delivery of access to trachoma interventions. This definition includes, but is not limited to, refugees, internally displaced persons (IDPs), indigenous and nomadic populations, people with disabilities, and people who experience homelessness.

supply chain

Includes recommendations related to shipments, drug transport, inventory management, drug deviation or theft, customs, clearance, handling, and other supply chain-related topics

suspected endemic

Geographic areas that national programs believe may be trachoma-endemic but have not yet undergone population-based trachoma prevalence surveys or other means of assessment. Includes recommendations from the TEC related to baseline surveys and expanison of coverage of trachoma prevalence mapping.

TEC meeting management

Refers to recommendations for the facilitation and management of the TEC meeting including but not limited to: the binder of applications and supporting materials produced by ITI (the TEC book), suggested invitiations, and recommendations for agenda items and presentations for future TECs

trichiasis

Includes references to trachomatous trichiasis and surgery for its management

Zithromax donation criteria

Refers to recommendations related to the conditions in which programs do or do not qualify for the Zithromax donation, the information the TEC will use to review Zithromax applications, and the decision categories the TEC will put each district into. This includes recommendations for the data that will be reviewed, the use of reserve categories, treatment guidelines for special populations, Zithromax for TT-surgery requests, and other decision making criteria.